An interventional study of Rhus Coriaria L.(Rhus) and Placebo in Body Weight, sponsored by Shiraz University of Medical Sciences. Completed at 1 site in Iran, Islamic Republic of. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-23.
Sponsored by Shiraz University of Medical Sciences · Not applicable, Interventional, and Treatment
The aim of this study is to evaluate the effects of Rhus coriaria L. (Rhus) commonly known as "Somagh" on body weight.
Rhus coriaria L.(Rhus) is a well-known spice widely consumed in the world which has also been utilized extensively for medicinal purposes. The antioxidant components of this plant made it a favorable target for laboratory and animal studies in different conditions such as oxidative stress cytotoxicity, diabetes and hyperlipidemia. Rhus (Somagh) is found in temperate and tropical regions worldwide, often growing in areas of marginal agricultural capacity. Rhus is used as an herbal remedy in traditional medicine because of its assumed analgesic, antidiarrheic, antiseptic, anorexic and antihyperglycemic properties. The fruits of Rhus contain flavonols, phenolic acids, hydrolysable tannins, anthocyans and organic acids such as malice, citric and tartaric acids. Some studies have shown that polyphenols could have beneficial effects on cardiovascular disease and cancer and could be regarded as bioactive compounds with a high potential health-promoting capacity. Phenolic compounds inhibit lipid peroxidation, scavenge the superoxide anion and hydroxyl radical, and enhance the activities of detoxifying enzymes.
The aim of this study is to evaluate the effects of Rhus coriaria L. (Rhus) commonly known as Somagh on body weight.
1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.
This study's enrollment of 50 is below the median of 64 across 947 interventional studies indexed under Body Weight.
Browse Body Weight studies →Shiraz University of Medical Sciences is the lead sponsor of 129 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
500 mg twice daily after meal for 6 weeks
Drug: Rhus Coriaria L.(Rhus)
500 mg twice daily after meal for 6 weeks
Drug: Placebo
500 mg twice daily after meals for 6 weeks
Also known as: Somagh
500 mg twice daily after meals for 6 weeks
Body Mass Index
Time frame: 6 weeks
Waist Circumference (cm)
Time frame: 6 weeks
Hip Circumference (cm)
Time frame: 6 weeks
Leptin (ng/ml)
Time frame: 6 weeks
Insulin (mU/l)
Time frame: 6 weeks
Fasting Blood Glucose (mg/dl)
Time frame: 6 weeks
Number of patients with adverse event
Time frame: 6 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shiraz University of Medical Sciences